The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats

Li Wang, Takaaki Hasegawa, Masayuki Nadai, Isao Muraoka, Toshitaka Nabeshima, Nobuo Kato

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Abstract— The effect of lipopolysaccharide (LPS) isolated from Klebsiella pneumoniae O3 on the pharmacokinetic behaviour and metabolism of the xanthines, theophylline and 1‐methyl‐3‐propylxanthine (MPX), which are mainly metabolized by the liver, was investigated in rats. LPS was infused at 0·25 mg kg−1 over a period of 20–30 min, 2 h before the administration of theophylline (10 mg kg−1) or MPX (2·5 mg kg−1). Concentrations of both xanthines in plasma and concentrations of the parent drug and metabolites in urine were measured by HPLC. Model‐independent methods were applied to estimate the pharmacokinetic parameters for both xanthines. No significant changes in the pharmacokinetic parameters or metabolism of theophylline were observed in rats pretreated with LPS. However, the total body clearance and volume of distribution of MPX were significantly increased by pretreatments with LPS. Significant decreases in the binding capacity and number of binding sites on the albumin molecule were observed in the presence of LPS. Changes occurring in the protein binding behaviour as a result of the introduction of LPS is a primary factor which not only increases the volume of distribution but also increases total body clearance. These results indicate that LPS has no effect on the pharmacokinetics and metabolic pathway of theophylline although it changes the disposition of MPX due to decreases in the extent of the protein binding of MPX which is highly bound to protein. 1993 Royal Pharmaceutical Society of Great Britain

Original languageEnglish
Pages (from-to)34-38
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume45
Issue number1
DOIs
Publication statusPublished - 01-01-1993

Fingerprint

Xanthines
Lipopolysaccharides
Theophylline
Pharmacokinetics
Protein Binding
Klebsiella pneumoniae
Metabolic Networks and Pathways
Albumins
Binding Sites
High Pressure Liquid Chromatography
Urine
Liver

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Wang, Li ; Hasegawa, Takaaki ; Nadai, Masayuki ; Muraoka, Isao ; Nabeshima, Toshitaka ; Kato, Nobuo. / The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats. In: Journal of Pharmacy and Pharmacology. 1993 ; Vol. 45, No. 1. pp. 34-38.
@article{e1b9addd1b604d888b2b920baa2448f6,
title = "The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats",
abstract = "Abstract— The effect of lipopolysaccharide (LPS) isolated from Klebsiella pneumoniae O3 on the pharmacokinetic behaviour and metabolism of the xanthines, theophylline and 1‐methyl‐3‐propylxanthine (MPX), which are mainly metabolized by the liver, was investigated in rats. LPS was infused at 0·25 mg kg−1 over a period of 20–30 min, 2 h before the administration of theophylline (10 mg kg−1) or MPX (2·5 mg kg−1). Concentrations of both xanthines in plasma and concentrations of the parent drug and metabolites in urine were measured by HPLC. Model‐independent methods were applied to estimate the pharmacokinetic parameters for both xanthines. No significant changes in the pharmacokinetic parameters or metabolism of theophylline were observed in rats pretreated with LPS. However, the total body clearance and volume of distribution of MPX were significantly increased by pretreatments with LPS. Significant decreases in the binding capacity and number of binding sites on the albumin molecule were observed in the presence of LPS. Changes occurring in the protein binding behaviour as a result of the introduction of LPS is a primary factor which not only increases the volume of distribution but also increases total body clearance. These results indicate that LPS has no effect on the pharmacokinetics and metabolic pathway of theophylline although it changes the disposition of MPX due to decreases in the extent of the protein binding of MPX which is highly bound to protein. 1993 Royal Pharmaceutical Society of Great Britain",
author = "Li Wang and Takaaki Hasegawa and Masayuki Nadai and Isao Muraoka and Toshitaka Nabeshima and Nobuo Kato",
year = "1993",
month = "1",
day = "1",
doi = "10.1111/j.2042-7158.1993.tb03675.x",
language = "English",
volume = "45",
pages = "34--38",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "1",

}

The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats. / Wang, Li; Hasegawa, Takaaki; Nadai, Masayuki; Muraoka, Isao; Nabeshima, Toshitaka; Kato, Nobuo.

In: Journal of Pharmacy and Pharmacology, Vol. 45, No. 1, 01.01.1993, p. 34-38.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats

AU - Wang, Li

AU - Hasegawa, Takaaki

AU - Nadai, Masayuki

AU - Muraoka, Isao

AU - Nabeshima, Toshitaka

AU - Kato, Nobuo

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Abstract— The effect of lipopolysaccharide (LPS) isolated from Klebsiella pneumoniae O3 on the pharmacokinetic behaviour and metabolism of the xanthines, theophylline and 1‐methyl‐3‐propylxanthine (MPX), which are mainly metabolized by the liver, was investigated in rats. LPS was infused at 0·25 mg kg−1 over a period of 20–30 min, 2 h before the administration of theophylline (10 mg kg−1) or MPX (2·5 mg kg−1). Concentrations of both xanthines in plasma and concentrations of the parent drug and metabolites in urine were measured by HPLC. Model‐independent methods were applied to estimate the pharmacokinetic parameters for both xanthines. No significant changes in the pharmacokinetic parameters or metabolism of theophylline were observed in rats pretreated with LPS. However, the total body clearance and volume of distribution of MPX were significantly increased by pretreatments with LPS. Significant decreases in the binding capacity and number of binding sites on the albumin molecule were observed in the presence of LPS. Changes occurring in the protein binding behaviour as a result of the introduction of LPS is a primary factor which not only increases the volume of distribution but also increases total body clearance. These results indicate that LPS has no effect on the pharmacokinetics and metabolic pathway of theophylline although it changes the disposition of MPX due to decreases in the extent of the protein binding of MPX which is highly bound to protein. 1993 Royal Pharmaceutical Society of Great Britain

AB - Abstract— The effect of lipopolysaccharide (LPS) isolated from Klebsiella pneumoniae O3 on the pharmacokinetic behaviour and metabolism of the xanthines, theophylline and 1‐methyl‐3‐propylxanthine (MPX), which are mainly metabolized by the liver, was investigated in rats. LPS was infused at 0·25 mg kg−1 over a period of 20–30 min, 2 h before the administration of theophylline (10 mg kg−1) or MPX (2·5 mg kg−1). Concentrations of both xanthines in plasma and concentrations of the parent drug and metabolites in urine were measured by HPLC. Model‐independent methods were applied to estimate the pharmacokinetic parameters for both xanthines. No significant changes in the pharmacokinetic parameters or metabolism of theophylline were observed in rats pretreated with LPS. However, the total body clearance and volume of distribution of MPX were significantly increased by pretreatments with LPS. Significant decreases in the binding capacity and number of binding sites on the albumin molecule were observed in the presence of LPS. Changes occurring in the protein binding behaviour as a result of the introduction of LPS is a primary factor which not only increases the volume of distribution but also increases total body clearance. These results indicate that LPS has no effect on the pharmacokinetics and metabolic pathway of theophylline although it changes the disposition of MPX due to decreases in the extent of the protein binding of MPX which is highly bound to protein. 1993 Royal Pharmaceutical Society of Great Britain

UR - http://www.scopus.com/inward/record.url?scp=0027508728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027508728&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.1993.tb03675.x

DO - 10.1111/j.2042-7158.1993.tb03675.x

M3 - Article

C2 - 8094443

AN - SCOPUS:0027508728

VL - 45

SP - 34

EP - 38

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 1

ER -